For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251022:nRSV4526Ea&default-theme=true
RNS Number : 4526E Geiger Counter Ltd 22 October 2025
Geiger Counter Limited Plc
Monthly Investor Report 22 October 2025
(All Factsheet data is at 31 September 2025)
The full monthly factsheet is now available on the Company's website and a
summary can be found below.
NCIM - Geiger Counter Ltd - Fund Page for Geiger Counter Ltd
(https://ncim.co.uk/geiger-counter-ltd/)
Enquiries:
For the Investment Manager
Craig Cleland
Manulife CQS Investment Management
0207 201 5368
For the Company Secretary and Administrator
Summit Fund Services Jersey Limited
Christopher Foulds/Katie De La Cour
01534 825219/01534 825337
-----------------------------------------------------------------------
Fund Description
The objective of Geiger Counter Limited is to provide investors with the
potential for capital growth through investment primarily in the securities of
companies involved in the exploration, development and production of energy,
predominantly within the uranium industry. Up to 30% of the value of the
Company's investment portfolio may be invested in other resource- related
companies from outside the energy sector.
Portfolio Managers
Keith Watson and Robert Crayfourd
Key Advantages for the Investor
· Access to mining assets in the uranium sector
· May benefit from embedded subscription share
· Low correlation to major asset classes
Key Fund Facts(1)
Total Gross Assets £92.7m
Reference Currency GBP
Ordinary Shares:
Net Asset Value 72.45p
Mid-Market Price 59.20p
Net gearing(4) 13.27%
Discount (18.29%)
Ordinary Share and NAV Performance(2)
One Month Three Months One Year Three Years Five Years
(%) (%) (%) (%) (%)
NAV 20.13 44.01 32.89 49.57 332.02
Share Price 19.35 35.16 33.79 28.70 208.33
Commentary(3)
The fund NAV gained 20.1% over the month.
The World Nuclear Association (WNA) conference in London took place in
September, with the bulk of the worlds uranium producers and utilities
requiring supply. This saw a broad positive outlook for the sectors outlook
against the backdrop of increased demand for Nuclear to supply power to data
centres for AI. We note the fundamentals pointed to tight markets before the
incremental addition of demand from big tech. Microsoft were a notable
attendee, highlighting the importance of Nuclear in future power demand needs.
The latest bi-annual supply/demand report from the WNA highlighted that demand
is expected to jump by 28% in the next five years and double by 2040, with
current and projected uranium mined supply insufficient to meet that demand.
We note this data was produced as at 30th of June and does not include
production downgrades from Cameco, Kazatomprom and Paladin, nor does it
include incremental positive views on SMR's for data centres post that period.
Whilst spot price gets all the attention the majority of U3O8 is sold via term
contracts. The Term price lifted to $83/lb this month having stayed around
$79/lb for the prior year. Q4 is seasonally a stronger period for utility
contracting and with a mixture of life extensions and advancing plans for
SMR's there looks an increasing incentive for stronger contracting given low
utility inventories in the west, with just 14 months in the US.
The Sprott Physical Uranium Trust (SPUT) returned to a premium, allowing it to
issue equity and return to buying physical Uranium. This has been a material
driver of tightening supply/demand fundamentals.
Nexgen will have its first hearing re its federal permit on the 19th of
November, with the second
hearing scheduled for February 9th to 13th 2026. They have already received
their provincial
permit.
Gross Leverage(2) Commitment Leverage(3)
(%) (%)
Geiger Counter Ltd 114 114
CQS (UK) LLP
4th Floor, One Strand, London WC2N 5HR, United Kingdom
T: +44 (0) 20 7201 6900 | F: +44 (0) 20 7201 1200
CQS (US), LLC
152 West 57th Street, 40th Floor, New York, NY 10019, US
T: +1 212 259 2900 | F: +1 212 259 2699
Tavistock Communications
18 St. Swithin's Lane, London EC4N 8AD
T: +44 20 7920 3150 | geigercounter@tavistock.co.uk
Sources: (1)Summit Fund Services Jersey Limited, as at the last business day
of the month indicated at the top of this report. (2)Summit Fund Services
Jersey Limited /DataStream, as at the last business day of the month indicated
at the top of this report, total return performance net of fees and expenses
based on bid prices. These include historic returns and past performance is
not a reliable indicator of future results. The value of investments can go
down as well as up. Please read the important legal notice at the end of this
document. (3)Market data sourced from Bloomberg unless otherwise stated. The
Fund may since have exited some or all of the positions detailed in the
commentary. (4) BMO, UxC, Company data September 2023. (5) www.eia.gov
(http://www.eia.gov) . (6)CQS, as at the last business day of the month
indicated at the top of this report. For methodology details see Article 4(3)
of Directive 2011/61/EU (AIFMD) and Articles 6, 7, 9 and 10 of Delegated
Regulation 231/2013. (7)CQS, as at the last business day of the month
indicated at the top of this report. For methodology details see Article 4(3)
of Directive 2011/61/EU (AIFMD) and Articles 6, 8, 9, 10 and 11 of Delegated
Regulation 3231/2013.
The Company has announced the fifth Subscription Rights Price of 32.70 pence
on 1 May 2025. The exercise date for the fifth Subscription Right is expected
to be 30 April 2026.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DOCPKBBKABDDKKB
Copyright 2019 Regulatory News Service, all rights reserved